Efficacy of Addition and Subtracton of Xiaobanyin on Facial Hormone-Dependent Dermatitis and Effect on Level of Th1/Th2 Cell

ZHOU Jun-wu; XUE Su-qin

doi:10.13422/j.cnki.syfjx.20181430

您当前的位置：

首页 >

文章列表页 >

Efficacy of Addition and Subtracton of Xiaobanyin on Facial Hormone-Dependent Dermatitis and Effect on Level of Th1/Th2 Cell

更新时间：2024-01-04

- Efficacy of Addition and Subtracton of Xiaobanyin on Facial Hormone-Dependent Dermatitis and Effect on Level of Th1/Th2 Cell
- Chinese Journal of Experimental Traditional Medical Formulae Vol. 24, Issue 14, Pages: 176-181(2018)
- 作者机构：
- 作者简介：
- 基金信息：
- DOI：10.13422/j.cnki.syfjx.20181430
  CLC： R758.2
- Published：2018
- 稿件说明：
移动端阅览
ZHOU Jun-wu, XUE Su-qin. Efficacy of Addition and Subtracton of Xiaobanyin on Facial Hormone-Dependent Dermatitis and Effect on Level of Th1/Th2 Cell[J]. Chinese journal of experimental traditional medical formulae, 2018, 24(14): 176-181.
DOI：

ZHOU Jun-wu, XUE Su-qin. Efficacy of Addition and Subtracton of Xiaobanyin on Facial Hormone-Dependent Dermatitis and Effect on Level of Th1/Th2 Cell[J]. Chinese journal of experimental traditional medical formulae, 2018, 24(14): 176-181. DOI： 10.13422/j.cnki.syfjx.20181430.

摘要

目的：探讨消斑饮加减治疗面部激素依赖性皮炎(HDD)的疗效及对辅助性T细胞免疫炎症和皮肤屏障功能的影响。方法：将119例HDD患者采用分层区组，随机按数字表法分为对照组59例和观察组60例。对照组口服氯雷他定片，10 mg/次，1次/d；和硫酸羟氯喹片，0.2 g/次，2次/d。观察组在对照组治疗的基础上加服消斑饮加减，1剂/d。两组疗程均为连续治疗8周。记录治疗前后主观症状和客观皮损症状评分；进行治疗前后皮肤屏障功能检测；检测治疗前后干扰素-γ (IFN-γ)，白细胞介素-2(IL-2)，IL-4，IL-6，IL-10，IL-1，IL-13和肿瘤坏死因子-α(TNF-α)水平；进行治疗前后皮肤病生活质量指数(DLQI)评价。结果：观察组临床疗效总有效率为93.33%，高于对照组的79.66%(χ2＝4.778，P<0.05)；观察组患者症状积分低于对照组(P<0.01)；观察组患者的角质层含水量和皮脂含量均高于对照组，经皮水分丢失少于对照组(P<0.01)；观察组血清IFN-γ，IL-2水平均高于对照组，IL-4，IL-6，IL-10水平均低于对照组(P<0.01)；观察组血清IL-1，IL-13和TNF-α水平均低于对照组(P<0.01)；观察组患者的DLQI量表各维度评分及总分均低于对照组(P<0.01)。结论：消斑饮加减在西医治疗的基础上，可明显缓解HDD症状，提高临床疗效和生活质量，并具有调节Th1/Th2细胞因子，减轻炎症损伤，促进皮肤屏障功能修复的作用。

Abstract

Objective: To discuss the efficacy of addition and subtracton of Xiaobanyin on facial hormone-dependent dermatitis (HDD) and its effect on helper T cells immune inflammation and skin barrier function. Method: One hundred and nineteen patients with HDD were randomly divided into control group 59 cases and observation group 60 cases by random number table and hierarchical block designs. Patients in control group were given loratadine tablets

10 mg/time

1 time/day. And hydroxychloroquine sulfate tablets

0.2 g/time

2 times/days. In addition to the therapy of control group

patients in observation group were also given addition and subtracton of Xiaobanyin

1 dose/day. A course of treatment was 8 weeks. Before and after treatment

scores of subjective symptoms and objective skin injury were recorded. Skin barrier function

interferon-γ (IFN-γ)

interleukin-2(IL-2)

IL-4

IL-6

IL-10

IL-1

IL-13 and tumor necrosis factor-α (TNF-α) were detected. And dermatology life quality index (DLQI) was evaluated. Result: The total effect rate in observation group was 93.33%

which was higher than 79.66% in control group (χ2=4.778

P<0.05). Score of symptom in observation group was lower than that in control group (P<0.01). Water content of corneum and sebum in observation group were higher than those in control group

while transepidermal water loss was less than that in control group (P<0.01). And levels of IFN-γ and IL-2 were higher than those in control group

whereas levels of IL-4

IL-6

IL-10

IL-1

IL-13

TNF-α scores of DLQI and the total score were lower than those in control group (P<0.01). Conclusion: In addition to the therapy of western medicine treatment

addition and subtracton of Xiaobanyin can relieve the symptom of HDD and inflammatory injury

improve the quality of life and the clinical effect

regulate levels of Th1/Th2 cytokines and promote the recovery of skin barrier function.

关键词

Keywords

references

Views

下载量

CSCD

Alert me when the article has been cited

提交

Tools

Publicity Resources

Clinical Efficacy of Jianpi Yangxue Qufeng Decoction in Treating Patients with Blood Deficiency and Wind Dryness Type Atopic Dermatitis and Its Effect on Skin Barrier Function

Modified Yinpu Sini Simiao Shixiao palvis on Immune Inflammatory Factors of Patients with Long-term Sequelae of Pelvic Inflammatory Disease

Related Author

WANG Li-fen

YE Jian-zhou

YANG Xue-song

ZHANG Xiu-rong

HAO Hao

Related Institution

No data

AI问答

Postal code：100700
Tel：010-84076882 Email：syfjx_2010@188.com
Technical support is provided by Beijing Founder electronics co., LTD 京ICP备11006657号-10 京公网安备11010802024621
It is recommended to read the content of this site in Chrome&IE9+. Please switch to extreme mode in browser 360.
Cookies We use cookies to help provide and enhance our service and tailor content. By continuing, you agree to the use of cookies.

⁰